Drug intelligence / Profile preview

Magnesium EG Opti

Development stage
Unknown
Lead developer
Euro Generics
Modality
Small Molecules
Administration
Oral
01

Overview

Magnesium EG Opti is a dietary supplement developed and distributed by Euro Generics (EG), a Belgian pharmaceutical company and subsidiary of the STADA Group. It is formulated as film-coated tablets containing 225 mg of elemental magnesium derived from three organic salts: magnesium citrate, magnesium taurate, and magnesium glycerophosphate. These organic salts are specifically selected for their high bioavailability and superior gastrointestinal tolerance compared to inorganic magnesium compounds. The formulation also includes 0.7 mg of Vitamin B6 (pyridoxine) to support magnesium absorption and contribute to normal nervous system function. Magnesium EG Opti is indicated for the prevention and correction of magnesium deficiency, particularly during periods of increased physiological demand such as pregnancy, growth, intense physical activity, stress, and fatigue. It supports normal muscle function, helps prevent muscle cramps, and contributes to energy metabolism and the reduction of tiredness.

Brand names
Magnesium EG OptiMagnesium Opti EG
Other names
Magnesium EG Opti (supplement)

Beyond the preview

Go deeper on Magnesium EG Opti.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium EG Opti.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call